Position: Senior Regulatory Affairs Associate
Company: Novartis Pharmaceuticals
Representing: Pharmaceutical Industry
Julie has been a member of EDWG since May 2000, most recently from October 2012 to present. Her interest in CMI stems from the belief that the CMI is an important tool in achieving Quality Use of Medicines & should be readily accessible to everyone. As a pharmacist she has a good understanding of patient counselling & the value of a well written CMI.
Julie has over 15 years' experience in regulatory affairs in both Australia & New Zealand mainly with prescription medicines over a range of therapeutic areas, including Cardiovascular, Neuroscience & Pain. Over the years she has contributed to the Usability Guidelines for CMI: Writing about Medicines for People 3rd Edition, conducted CMI workshops, & written numerous CMI documents.
Julie was also a member of the Quality Assurance Reference Group (QARG) from February 2005 to September 2009. The prime objective of the QARG was to ensure that CMIs are written in a manner easily understood by the consumer.
